Personality profiles of normal healthy research volunteers: A potential concern for clinical drug trial investigators?

Medical Hypotheses

Volumn 65, Issue 1, 2005, Pages 1-7

  Tishler, Carl L ^a   Bartholomae, Suzanne ^a   Rhodes, Angel R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACCURACY; ANXIETY; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; EXTRAVERSION; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; NEUROSIS; PERSONALITY; PHARMACOLOGICAL PARAMETERS; PHYSIOLOGY; POPULATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SCREENING; SELF REPORT; STATISTICAL ANALYSIS; STOMACH EMPTYING; TYPE A BEHAVIOR; TYPE B BEHAVIOR; VOLUNTEER;

EID: 18944363633     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.01.018     Document Type: Article

References (43)

1. J.J. Schrogie, M.J. Hensley, C. Digiore, and S. Harris Evaluation of the prison inmate as a subject in drug assessment Clin Pharmacol Ther 21 1977 1 8
2. J. Cami, M. Llorente, M. Farre, J.M. Badenas, and B. Ugena Personality of healthy volunteers participating in Phase I clinical trials Pers Individ Dif 10 1989 1199 1200
3. P.L. Morselli Are phase I studies without drug level determination acceptable? Fundam Clin Pharmacol 4 Suppl 2 1990 125s 133s
4. M. Farre, X. Lamas, and J. Cami Sensation seeking amongst healthy volunteers participating in phase I clinical trials Br J Clin Pharmacol 39 1995 405 409
5. L. Weissman, J.D. Moore, G.B. Thomas, and E.N. Whitman Personality factors in prison volunteers related to response in clinical drug trials Clin Pharmacol Ther New Drugs 12 1972 5 10
6. F.J. Ayd Jr. Motivations and rewards for volunteering to be an experimental subject Clin Pharmacol Ther 13 1972 771 778
7. F. Meyer Psycho-and immunopharmacological factors relevant to selection of volunteers in clinical studies Int J Clin Pharmacol Ther 39 2001 300 310
8. National Bioethics Advisory Commission. Ethical and policy issues in research involving human participants. Bethesda, MD: National Bioethics Advisory Commission 2001
9. Healthcare Financing Administration. Available from: http://www.cms.hhs. gov. Retrieved December, 2004
10. Federal Medical & Health Research AAAS XXIII: Research and Development Report: FY, 1999
11. D. Schechter, T.M. Singer, J. Kuperman, and J. Endicott Selection of 'normal' control subjects for psychiatric research: update on a model for centralized recruitment Psychiatry Res 79 1998 175 185
12. G.K. Thaker, M. Moran, A. Lahti, H. Adami, and C. Tamminga Psychiatric morbidity in research volunteers Arch Gen Psychiatry 47 1990 980
13. D.W. Purcell, J.A.J. Schwartz, R.J. Brookshire, J. Caudle, and R.R.J. Lewine Neuropsychological functioning in "normal" subjects Neuropsychiatry Neurophychol Beh Neurol 8 1995 6 13
14. D. Berto, S. Milleri, L. Squassante, and P. Baroldi Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies Eur J Clin Pharmacol 51 1996 209 213
15. G. Apseloff, H.M. Ashton, H. Friedman, and N. Gerber The importance of measuring cotinine levels to identify smokers in clinical trials Clin Pharmacol Ther 56 1994 460 462
16. M. Pieters, A. Jennekens-Schinkel, H. Schoemaker, and A. Cohen Self-selection for personality variables among healthy volunteers Br J Clin Pharmacol 33 1992 101 106
17. D.L. Shtasel, R.E. Gur, and P.D. Mozley Volunteers for biomedical research: recruitment and screening of normal controls Arch Gen Psychiatry 48 1991 1022 1025
18. M.J. Kruesi, M.C. Lenane, E.D. Hibbs, and J. Major Normal controls and biological reference values in child psychiatry: defining normal J Am Acad Child Adolesc Psychiatry 29 1990 449 452
19. C.L. Tishler, and L.B. Gordon Ethical parameters of challenge studies inducing psychosis with ketamine Ethics Beh 9 1999 211 217
20. C.P. Gross, R. Mallory, A. Heiat, and H.M. Krumholz Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137 2002 10 16
21. C.L. Tishler, and S. Bartholomae The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives J Clin Pharmacol 42 2002 365 375
22. U. Halbreich, Y. Bakhai, and K.B. Bacon The normalcy of self-proclaimed 'normal volunteers' Am J Psychiatry 146 1989 1052 1055
23. J. Butler Is it ethical to conduct volunteer studies within the pharmaceutical industry Lancet 1 1978 816 818
24. P. Joubert, L. Rivera-Calimlim, and L. Lasagna Commentary. The normal volunteer in clinical investigation: how rigid should selection criteria be Clin Pharmacol Ther 17 1975 253 257
25. US Food and Drug Administration. General considerations for the clinical evaluation of drugs. Rockville, MD: US Food and Drug Administration, 1979
26. F. Meyer, R. Haschke, and F. Rohl The healthy volunteer in clinical pharmacology: personality and motivation Eur J Clin Pharmacol 48 1995 91 96
27. D. Ong, A. Popat, S.R. Knowles, J.S. Arrowood, N.H. Shear, and K.E. Binkley Objective psychological measurement and clinical assessment of anxiety in adverse drug reactions Can J Clin Pharmacol 11 2004 e8 e16
28. TM) auf die reaktionsfahigkeit und die subjective Befindlichkeit gesunder Probnden - ein Beitrag zur differentiellen Psychopharmakologie Z klin Med 40 1985 673 676
29. S. Nakano, N. Ogawa, and Y. Kawazu Influence of neuroticism on oral absorption of diazepam Clin Pharmacol Ther 27 1980 370 374
30. S.H. Jackson, C.A. Cooper, and T.H. Turner Personality and theophylline pharmacokinetics Eur J Clin Pharmacol 28 1985 429 431
31. J.A. Walsh, and M.M. Nash Personality characteristics of volunteers for medical research Crim Justice Beh 5 1978 99 116
32. C.J. Ball, P.M. McLaren, and P.J. Morrison The personality structure of 'normal' volunteers Br J Clin Pharmacol 36 1993 369 371
33. F.P. Meyer, U. Troger, and F. Rohl Pharmacoepidemiology and drug utilization - adverse nondrug reactions: an update Clin Pharmacol Ther 60 3 1996 347 352
34. P.J. Feldman, S. Cohen, W.J. Doyle, D.P. Skoner, and J.M.J. Gwaltney The impact of personality on the reporting of unfounded symptoms and illness J Pers Soc Psychol 77 1999 370 378
35. M.-D. Drici, F. Raybaud, C. De Lunardo, P. Iacono, and P. Gustovic Influence of the behavior pattern on the nocebo response of healthy volunteers Br J Clin Pharmacol 39 1995 204 206
36. A.F. Bogaert Volunteer bias in human sexuality research: evidence for both sexuality and personality differences in males Arch Sex Beh 25 1996 125 140
37. W. Pollin, and S. Perlin Psychiatric evaluation of normal control volunteers Am J Psychiatry 115 1958 129 133
38. Cone J, Foster S. Dissertations and theses from start to finish: psychology and related fields. Washington, DC: American Psychological Association; 2001
39. C.L. Tishler, and S. Bartlolomae Repeat participation among normal healthy volunteers: professional guinea pigs in clinical trials Perspect Biol Med 4 2003 508 520
40. C. Gorenstein, F. Lotufo-Neto, M. Melo, and V. Lauriano Untreated psychopathology of candidates to normal volunteers J Clin Psychopharmacol 17 1997 238 239
41. K.S. Kendler The super-normal control group in psychiatric genetics: possible artifactual evidence for coaggregation Psychiatric Genet 1 1990 45 53
42. S.C. Risch, R.J. Lewine, R.D. Jewart, M.B. Eccard, J.S. McDaniel, and E.D. Risby Ensuring the normalcy of normal volunteers Am J Psychiatry 147 1990 682 683
43. G. Apseloff, J.K. Swayne, and N. Gerber Medical histories may be unreliable in screening volunteers for clinical trials Clin Pharmacol Ther 60 1996 353 356